Turoctocog alfa is safe for the treatment of Indian patients with hemophilia A: Guardian 10 trial results

BACKGROUND: Hemophilia A is an X chromosome–linked bleeding disorder caused by the deficiency of coagulation factor VIII (FVIII). The majority of the Indian population with hemophilia A use plasma‐derived clotting factors and, in some instances, fresh frozen plasma and cryoprecipitate. Safer and mor...

Descripción completa

Detalles Bibliográficos
Autores principales: John, M. Joseph, Chakrabarti, Prantar, Apte, Shashikant, Bhattacharyya, Maitreyee, S., Chandrakala, Hansen, Trine, Kolla, Rohan, Ross, Cecil, Seth, Tulika, Siddharthan, Neeraj, Abraham, Aby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles ‐ Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695559/
https://www.ncbi.nlm.nih.gov/pubmed/33313471
http://dx.doi.org/10.1002/rth2.12441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695559/
https://www.ncbi.nlm.nih.gov/pubmed/33313471
http://dx.doi.org/10.1002/rth2.12441

Ejemplares similares